Michael Schaapveld

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond et al. · New England Journal of Medicine · 2015 · 626 citations · Full text

Medicine, Oncology, Cancer Control +13

Cardiovascular Disease After Hodgkin Lymphoma Treatment

Frederika A. van Nimwegen, Michael Schaapveld, Cécile P.M. Janus et al. · JAMA Internal Medicine · 2015 · 502 citations · Full text

Medicine, Cardiology, Oncology +15

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma

Frederika A. van Nimwegen, Michael Schaapveld, David J. Cutter et al. · Journal of Clinical Oncology · 2015 · 458 citations

Medicine, Oncology, Radiation Oncology +17

Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood

Flora E. van Leeuwen, Willem J. Klokman, Mars B. vanʼt Veer et al. · Journal of Clinical Oncology · 2000 · 438 citations

Medicine, Oncology, Cancer Epidemiology +16

Morbidity and mortality of inadvertent enterotomy during adhesiotomy

A A van der Krabben, Frederika Dijkstra, Marieke E. van de Nieuwenhuijzen et al. · British journal of surgery · 2000 · 400 citations

Medicine, Perioperative Medicine, Surgery +17